MedPath

Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction

Completed
Conditions
Contraception
Interventions
Registration Number
NCT01590537
Lead Sponsor
Bayer
Brief Summary

This is local prospective, non-interventional multi-center comparative study. Primary study objective is evaluation of the user satisfaction with Mirena or Copper IUD up to 1 year after insertion ( patient assessment questionnaire) in daily practice. For each patient, the treating gynecologist documents demographics, medical data, safety parameters and treatment signs and symptoms at an initial visit and one or two follow-up visit(s).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
2348
Inclusion Criteria
  • Women 20-40 years old
  • Parity ≥ 1 child
  • Requesting long-term contraception
  • Written informed consent.
Read More
Exclusion Criteria
  • in accordance with the current leaflet
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 1Levonorgestrel (Mirena, BAY86-5028)-
Group 2Copper IUD-
Primary Outcome Measures
NameTimeMethod
User satisfaction of the contraception method with Mirena or Copper IUDup to 12 months
Secondary Outcome Measures
NameTimeMethod
Continuation/discontinuation rate ( number of cases with contraceptive method continuation and discontinuations)up to 12 months
Safety evaluation of Mirena or Copper IUD in routine practice Safety parameters include number of AEs, severity,relationship to Mirena or Cooper IUDup to 12 months
Relationship between different parameters and women preferences in choosing Mirena or Cooper IUD as their contraceptive method ( demographic parameters, age group, residence, reproductive history and plans, etc.) using patients questionnaireup to 12 months
Contraceptive reliability of Mirena or Cooper IUD in routine practice ( fixing number of pregnancies)up to 12 months
© Copyright 2025. All Rights Reserved by MedPath